Studies on the in vitro assembly of Aβ 1-40: Implications for the search for Aβ fibril formation inhibitors

Journal of Structural Biology

Volumn 130, Issue 2-3, 2000, Pages 217-231

  Goldsbury, Claire S ^a   Wirtz, Sabine ^a   Müller, Shirley A ^a   Sunderji, Shabir ^b   Wicki, Peter ^b   Aebi, Ueli ^a   Frey, Peter ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Alzheimer's disease; A ; Congo red; Electron microscopy; Fibril formation; Fluorescence; Thioflavin T; Turbidity

Indexed keywords

AMYLOID BETA PROTEIN; CONGO RED; THIOFLAVINE;

ALZHEIMER DISEASE; ARTICLE; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; MOLECULAR DYNAMICS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY;

EID: 0033849965     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.2000.4259     Document Type: Article

References (64)

1. Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin
2. Morphological development of β(1-40) amyloid fibrils
3. Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide
4. Molecular modeling of the Aβ1-42 peptide from Alzheimer's disease
5. X-ray diffraction studies on amyloid filaments
6. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease
7. Polymorphism of reconstituted human epidermal keratin filaments: Determination of their mass-per-length and width by scanning transmission electron microscopy (STEM)
8. Application of scanning transmission electron microscopy to the study of biological structure
9. Aβ deposition inhibitor screen using synthetic amyloid
10. Modified-peptide inhibitors of amyloid β-peptide polymerization
11. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution
12. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
13. Polymorphic fibrillar assembly of human amylin
14. Watching amyloid fibrils grow by time-lapse atomic force microscopy
15. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
16. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein
17. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
18. Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease
19. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
20. The toxicity in vitro of β-amyloid protein
21. Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide
22. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie
23. Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red Aβ (CR-Aβ) spectrophotometric assay
24. Amyloid diseases: Abnormal protein aggregation in neurodegeneration
25. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains
26. 1-42 are potent central nervous system neurotexins
27. The molecular mechanism of amyloid formation in Alzheimer's disease
28. Amyloid fibrils may be assembled from β-helical protofibrils
29. Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
30. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer β(1-40) amyloid fibrils
31. An atomic model for the pleated β-sheet structure of Aβ amyloid protofilaments
32. On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants
33. Kinetic theory of fibrillogenesis of amyloid β-protein
34. Effect of viscosity and temperature on torsional relaxation of molecular rotors
35. Structural analysis of Alzheimer's β(1-40) amyloid: Protofilament assembly of tubular fibrils
36. The importance of inflammatory mechanisms in Alzheimer disease
37. Factors influencing the precision of quantitative scanning transmission electron microscopy
38. 1-42 fibrillogenesis
39. Recognition sequence design for peptidyl modulatiors of β-amyloid aggregation and toxicity
40. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
41. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures
42. Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy
43. Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture
44. Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by congo red
45. Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
46. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
47. Translating cell biology into therapeutic advances in Alzheimer's disease
48. Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs
49. The molecular basis of amyloidosis
50. Effect of acid predissolution on fibril size and fibril flexibility of synthetic β-amyloid peptide
51. Solvent effects on self-assembly of β-amyloid peptide
52. High resolution electron microscopic analysis of the amyloid fibril
53. The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation
54. Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure
55. The nanometer-scale structure of amyloid-β visualized by atomic force microscopy
56. The biophysics of amyloid β-protein fibrillogenesis
57. A molecular model of Alzheimer amyloid β-peptide fibril formation
58. 23 residue affects the aggregation properties of Alzheimer amyloid β protein analogues
59. Amyloid β-protein fibrillogenesis - Detection of a protofibrillar intermediate
60. Amyloid β-protein fibrillogenesis - Structure and biological activity of protofibrillar intermediates
61. Solution structure of methionine-oxidized amyloid β-peptide (1-40). Does oxidation affect conformational switching?
62. Selective inhibition of Aβ fibril formation
63. Mechanisms of neuronal degeneration in Alzheimer's disease
64. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease